PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Tex18]

Is it conceivable that the “financing problem” is being handled by hopes of Chiesi milestone payments? Wouldn’t submitting their application to the FDA trigger a milestone. Did i misunderstand that happening around April/May time frame. And am i correct in my recollection we do not know the precise details of the size of the milestone payments?

I recall seeing as trials are enrolled clinical expenses should decrease which lessens cash burn. Also we don’t fully know how much they offset with Brazil sales. I think that was a few million. There is the potential for those to offset and cash runway to endure slightly longer. No?

Fact-checks are appreciated as I haven’t had the chance to dive deeper recently. Been following very loosely.